Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy

Seroclearance of hepatitis B surface antigen (HBsAg) (“functional cure”) is the optimal endpoint of antiviral therapy for chronic hepatitis B virus (HBV) infection. Currently available anti-HBV therapy includes nucleoside/nucleotide analogs (NAs) and peginterferon-α (Peg-IFNα). Combination of NAs an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Kanako, Enomoto, Masaru, Tamori, Akihiro, Nishiguchi, Shuhei, Kawada, Norifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867160/
https://www.ncbi.nlm.nih.gov/pubmed/33535672
http://dx.doi.org/10.3390/ijms22031456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867160/
https://www.ncbi.nlm.nih.gov/pubmed/33535672
http://dx.doi.org/10.3390/ijms22031456

Ejemplares similares